Literature DB >> 11961631

Nurse-led direct access endoscopy clinics: the future?

P S Basnyat1, K F Gomez, J West, P S Davies, M E Foster.   

Abstract

BACKGROUND: Many studies have shown that rectal bleeding is a good indicator of underlying colorectal pathology, and that ost of the lesions in patients presenting with rectal bleeding lie in the left side of the colon [1, 5, 9, 12, 23, 26]. The recent acceptance of the nurse-practitioner by the National Health Service may allow the use of nurse-endoscopists to develop throughout the United Kingdom. This study aimed to audit a unique nurse-led direct-access nurse-endoscopy service with regard to its efficacy and cost effectiveness, and to monitor patient satisfaction and direct referrals from the primary health sector.
METHODS: A nurse-led open-access flexible sigmoidoscopy (OAFS) service for patients reporting fresh rectal bleeding was established at our center in February 1996. A prospective audit of sigmoidoscopic findings and a retrospective analysis of referral patterns from local general practitioners were conducted. A questionnaire survey of both patient and general practitioner satisfaction also was conducted at the same time.
RESULTS: Since February 1996, 706 patients have been referred to our service. Rectal bleeding was by far the most common cause for referral, representing the dominant symptom in 92% of the referrals received. Although 99% of the patients underwent a complete sigmoidoscopic examination, 16% of these examinations were limited because of several factors combined. A cause for bleeding was identified in 91% of the patients, with 24% of them experiencing subsequent significant pathology. Of the patients surveyed, 99% were satisfied with the service provided. The results also show nurse-led OAFS to be a more effective use of financial resources, costing $90 less per patient than general practitioner referrals sent to a consultant for further action.
CONCLUSIONS: Rectal bleeding is a good indicator of underlying colorectal disease. Most of the significant lesions presenting with this symptom are found in the left side of the colon. A nurse-led OAFS is safe, effective, and acceptable to patients. It also is more cost effective than a consultant-led service.

Entities:  

Mesh:

Year:  2001        PMID: 11961631     DOI: 10.1007/s004640090120

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

Review 1.  Management of colorectal cancers.

Authors:  R Lewis; A Flynn; M E Dean; A Melville; A Eastwood; A Booth
Journal:  Qual Saf Health Care       Date:  2004-10

2.  The promises and perils of nurse-led flexible sigmoidoscopy screening.

Authors:  Paul Moayyedi
Journal:  Can J Gastroenterol       Date:  2007-05       Impact factor: 3.522

3.  How important is it to investigate the whole of the colon after initial assessment at a rapid access colorectal clinic?

Authors:  Chung Sim Lim; Linnet McGeever; Judith Helen Grey; Arunachalam Krishna; Aijaz Ahmed Jabbar; Wilson Stephen Hendry
Journal:  Int J Colorectal Dis       Date:  2009-06-05       Impact factor: 2.571

4.  Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Authors:  Claire Friedemann Smith; Alice C Tompson; Nicholas Jones; Josh Brewin; Elizabeth A Spencer; Clare R Bankhead; Fd Richard Hobbs; Brian D Nicholson
Journal:  Br J Gen Pract       Date:  2018-08-13       Impact factor: 5.386

5.  Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.

Authors:  E M L Verschuur; E W Steyerberg; H W Tilanus; S Polinder; M-L Essink-Bot; K T C Tran; A van der Gaast; L P S Stassen; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

6.  Direct access from general practice to transvaginal ultrasound for early detection of ovarian cancer: a feasibility study.

Authors:  Marie-Louise Ladegaard Baun; Margit Dueholm; Hanne Nørgaard Heje; William Hamilton; Lone Kjeld Petersen; Peter Vedsted
Journal:  Scand J Prim Health Care       Date:  2021-06-07       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.